HLA-DR/CD3

SKU: HLADRF3PE1-50T Categories: ,

251,24  VAT excl.

Human lymphocytes may be divided into three major populations based on their biologic function and cell-surface antigen expression: T lymphocytes, B lymphocytes, and natural killer (NK) lymphocytes. T lymphocytes participate in antigen-specific cell-mediated immunity and regulate the secretion of immunoglobulin by B lymphocytes. T lymphocytes may also be classified based on their functional properties as helper/inducer, suppressor/cytotoxic, or activated T lymphocytes.
Activated T lymphocytes (HLA-DR + T lymphocytes) may be elevated in states of immune activation, which may be caused by infection or impending transplant rejection. The actual cause of immune activation must be verified by additional clinical and laboratory tests.

Additional information

Conjugated

Size

Clone

Format

Species Reactivity

Isotype

Tested Applications

Regulatory Status

Storage Store in the dark at 2-8°C.
Buffer

The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide (NaN3).

Immunogen

The anti-HLA-DR monoclonal antibody derives from mononuclear cell leukemia acute undifferentiated.
The anti-CD3 monoclonal antibody derives from human leukocytes.

Concentration

Please refer to the Certificate of Analysis for the lot-specific concentration. Typically 0,05 mg/ml.